The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia

被引:0
|
作者
Patricia S Goldman-Rakic
机构
[1] Section of Neurobiology,
[2] Yale University School of Medicine,undefined
来源
Neuropsychopharmacology | 1999年 / 21卷
关键词
Dopamine D; receptors; Prefrontal cortex; Memory; Cognition; Schizophrenia; Cognitive deficits; Antipsychotics;
D O I
暂无
中图分类号
学科分类号
摘要
An understanding of the role of the prefrontal cortex in normal cognitive processes has advanced our comprehension of the pathophysiology underlying the cognitive deficits in schizophrenia. Studies of single-neuron activity in monkeys during performance of delayed-response tasks have confirmed the involvement of the prefrontal cortex in working memory. The “memory fields” of prefrontal neurons are analogous to the receptive fields of visual neurons and the cellular expression of a working memory process that allows mnemonic information to guide behavior. D1-dopamine antagonists produce a dose-dependent effect (U-shaped) on the firing rate of cells with memory fields during delayed-response tasks. Disordered cognitive processes in schizophrenia can be attributed to impairment of function in the prefrontal cortex, as evidenced by hypometabolic activity in the prefrontal cortex and selective impairment in working memory tasks. Advances in our understanding of the role of D1 receptors in the cognitive deficits observed in schizophrenia should provide us with a rational basis for developing alternative antipsychotic treatments and may provide insight into the cellular basis of the disorder.
引用
收藏
页码:S170 / S180
相关论文
共 50 条
  • [41] Microinjection of a dopamine-D1 receptor agonist into the ventral tegmental area reverses the blocked expression of morphine conditioned place preference by N-methyl-D-aspartate receptor antagonist
    Ahmadian, Seyed Mostafa
    Ghahremani, Parisa
    Alaei, Hojjatallah
    ADVANCED BIOMEDICAL RESEARCH, 2020, 9 (01): : 54
  • [42] New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
    Urs, Nikhil M.
    Peterson, Sean M.
    Caron, Marc G.
    BIOLOGICAL PSYCHIATRY, 2017, 81 (01) : 78 - 85
  • [43] THE RELEVANCE OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND HOW TO TREAT THEM WITH PSYCHOPHARMACEUTICALS?
    Moeller, Hans-Juergen
    PSYCHIATRIA DANUBINA, 2016, 28 (04) : 435 - 440
  • [44] A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia
    Shah, A.
    Lodge, D. J.
    TRANSLATIONAL PSYCHIATRY, 2013, 3 : e215 - e215
  • [45] History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
    Madras, Bertha K.
    JOURNAL OF THE HISTORY OF THE NEUROSCIENCES, 2013, 22 (01) : 62 - 78
  • [46] A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
    Osborne, Ashleigh L.
    Solowij, Nadia
    Weston-Green, Katrina
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 72 : 310 - 324
  • [47] Targeting the dopamine D2 receptor in schizophrenia
    Seeman, Philip
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 515 - 531
  • [48] QUANTITATIVE AUTORADIOGRAPHY OF DOPAMINE-D1 RECEPTORS, D2 RECEPTORS, AND DOPAMINE UPTAKE SITES IN POSTMORTEM STRIATAL SPECIMENS FROM SCHIZOPHRENIC-PATIENTS
    KNABLE, MB
    HYDE, TM
    HERMAN, MM
    CARTER, JM
    BIGELOW, L
    KLEINMAN, JE
    BIOLOGICAL PSYCHIATRY, 1994, 36 (12) : 827 - 835
  • [49] The Impact of Motivation on Cognitive Performance in an Animal Model of the Negative and Cognitive Symptoms of Schizophrenia
    Ward, Ryan D.
    Winiger, Vanessa
    Higa, Kerin K.
    Kahn, Julia B.
    Kandel, Eric R.
    Balsam, Peter D.
    Simpson, Eleanor H.
    BEHAVIORAL NEUROSCIENCE, 2015, 129 (03) : 292 - 299
  • [50] Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
    McCutcheon, Robert A.
    Abi-Dargham, Anissa
    Howes, Oliver D.
    TRENDS IN NEUROSCIENCES, 2019, 42 (03) : 205 - 220